Search Within

Gabriella D'Andrea-Carlino

Formats
  1. Meeting Abstract (41)
  2. Journal Article (37)
Groups
  1. Breast Medicine Service (78)
  2. Department of Medicine (78)
  3. Solid Tumor Oncology Division (78)
  4. Survivorship Research (78)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (56)
  6. Epidemiology and Biostatistics (55)

More Groups

People
  1. Clifford Hudis (64)
  2. Larry Norton (45)
  3. Diana Lake (39)
  4. Monica Fornier (38)
  5. Andrew Seidman (36)
  6. Chau Dang (33)

More People

Years
  1. 2023 (1)
  2. 2021 (2)
  3. 2020 (1)
  4. 2018 (3)
  5. 2017 (2)
  6. 2016 (2)

More Years

Publications
  1. Journal of Clinical Oncology (24)
  2. Cancer Research (11)
  3. Breast Cancer Research and Treatment (9)
  4. Clinical Cancer Research (9)
  5. Clinical Breast Cancer (8)
  6. Annals of Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (24)
  2. American Association for Cancer Research (20)
  3. Elsevier Inc. (10)
  4. Springer (10)
  5. Oxford University Press (4)
  6. Wiley Blackwell (4)

More Publishers

Results (78)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dose-dense (DD) cyclophosphamide, methotrexate, and fluorouracil (CMF) at 14-day intervals: A pilot study of every 14- and 10-11-day dosing intervals for women with early-stage breast cancer
    Meeting Abstract

    Drullinsky, P.; Fornier, M. N.; Sugarman, S.; D'Andrea, G.; Troso-Sandoval, T.; Seidman, A. D.; Yuan, J.; Patil, S.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Androgen receptor inhibition can stabilize disease in patients with AR(+), ER(-)/PR(-) metastatic breast cancer
    Meeting Abstract

    Traina, T. A.; Feigin, K.; Patil, S.; Yuan, J.; Dickler, M.; Andrea, G. D.; Bromberg, J.; Hudis, C.
    Annals of Oncology (2009)

    Fulltext@MSK | Save
  • Dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by weekly paclitaxel (P) with trastuzumab (T) and lapatinib (L) in HER2/neu-positive breast cancer is not feasible due to excessive diarrhea: Updated results
    Meeting Abstract

    Dang, C.; Lin, N.; Moy, B.; Come, S.; Lake, D.; Theodoulou, M.; Troso-Sandoval, T.; Dickler, M.; Gorsky, M.; D'Andrea, G.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinoma
    Journal Article

    Sugarman, S.; Wasserheit, C.; Hodgman, E.; Coglianese, M.; D'alessandro, A.; Fornier, M.; Troso-Sandoval, T.; D'Andrea, G.; Drullinsky, P.; Lake, D.; more...
    Breast Cancer Research and Treatment (2009)

    Fulltext@MSK | Save
  • A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: Immunological effects
    Journal Article

    Deng, G.; Lin, H.; Seidman, A.; Fornier, M.; D'Andrea, G.; Wesa, K.; Yeung, S.; Cunningham Rundles, S.; Vickers, A. J.; Cassileth, B.
    Journal of Cancer Research and Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients
    Meeting Abstract

    Deng, G.; Smith-Jones, H. L.; Seidman, A. D.; Fornier, M.; D'Andrea, G.; Wesa, K.; Cunningham-Rundles, S.; Yeung, K. S.; Vickers, A.; Cassileth, B. R.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Phase II trial of patupilone in patients (pts) with breast cancer brain metastases (BCBM) progressing or recurring after whole brain radiation therapy (WBXRT)
    Meeting Abstract

    Conlin, A. K.; D'Andrea, G.; Hudis, C. A.; Robson, M. E.; Drullinsky, P.; Theodoulou, M.; Lis, E.; Kang, T. Y.; Peereboom, D. M.; Seidman, A. D.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Phase II study of weekly nanoparticle albumin bound (nab)paclitaxel with carboplatin and trastuzumab as 1st-line therapy for HER2-positive metastatic breast cancer (MBC)
    Meeting Abstract

    Seidman, A. D.; Conlin, A. K.; Bach, A.; Brufsky, A. M.; Saleh, M. N.; Lake, D.; Dickler, M. N.; D'Andrea, G.; Traina, T. A.; Hudis, C. A.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • A survey of sleep problems in survivors of breast cancer
    Meeting Abstract

    Passik, S.; Starr, T.; Massie, M. J.; McCabe, M.; Holland, J.; Norton, L.; di Ciccone, B. L.; Li, Y. L.; Reinsel, R.; D'Andrea, G.; more...
    Psycho-Oncology (2008)

    Fulltext@MSK | Save
  • A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer
    Journal Article

    Dickler, M. N.; Rugo, H. S.; Eberle, C.; Brogi, E.; Caravelli, J.; Panageas, K. S.; Boyd, J.; Yeh, B.; Lake, D. E.; Dang, C.; more...
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save